EspeRare, Dermelix to develop in utero therapy for rare disease
Dermelix partnered with the EspeRare Foundation to develop DMX-101 for X-linked hypohydrotic ectodermal dysplasia, a rare
Gathering data...
Dermelix partnered with the EspeRare Foundation to develop DMX-101 for X-linked hypohydrotic ectodermal dysplasia, a rare